润都股份：硫酸氨基葡萄糖氯化钠复盐化学原料药上市获批

Group 1 - The core point of the article is that Rundu Co., Ltd. has received approval from the National Medical Products Administration for the marketing application of Glucosamine Sulfate Sodium Chloride Compound, which is indicated for the treatment of primary and secondary osteoarthritis [1] Group 2 - The approved drug is specifically aimed at treating osteoarthritis, a common joint condition that affects many individuals [1]